Volume 31 Archives - GEN - Genetic Engineering and Biotechnology News

GEN Magazine

, Volume 31

Website Content From This Issue

Website Content from This Issue

Sequencing Alters Medical Genetics

December 1, 2011

Systems Biology Delivers Higher Level Analysis

December 1, 2011

Maintaining a Steadfast Commitment to NIH Funding

December 1, 2011

Stem Cell Research in the EU and U.S.

December 1, 2011

Cell Growth Takes on New Dimension

December 1, 2011

Protein Purification Reagent Market Expands

December 1, 2011

GEN’s 30th Anniversary: Bacteria Combat Waste

December 1, 2011

Biotech Takes Hit from Jittery Market in Q3

December 1, 2011

Emerging Trends for Predictive Toxicology

December 1, 2011

Multiplexing Ignites Biomarker Research

December 1, 2011

High Sensitivity Analysis of Fentanyl

December 1, 2011

Analysis of Multiple Angiogenesis Analytes

December 1, 2011

Epigenetic-Derived Therapies on Horizon

December 1, 2011

Keeping Sample Preparation Simple

December 1, 2011

Streamlining Multiplex PCR Analysis

December 1, 2011

Filtration Products Steadily Evolving

December 1, 2011

New Filtration Technologies Enable a Reduction in Process Steps

December 1, 2011

Cell Culture Media Optimization

December 1, 2011

Reimbursement in Personalized Medicine

December 1, 2011

Gene Therapy Briefs

December 1, 2011

Flow Cytometry Shifting Gears

November 15, 2011

FSPs Provide an Option to Traditional CRO Approach

November 15, 2011

Syn Bio Delivers Cool Tools but Drugs Are a Ways Off

November 15, 2011

Samsung Stakes Out Biopharma Position

November 15, 2011

GEN’s 30th Anniversary: Molecular Diagnostics

November 15, 2011

Infectious Disease Molecular Diagnostics

November 15, 2011

Microfluidics Making Bigger Impression

November 15, 2011

Stain-Free Approach for Western Blotting

November 15, 2011

Gene-Expression Profiling Finds Niche

November 15, 2011

Advances in Sophisticated Genome Editing

November 15, 2011

Improving Classic Antibody Engineering

November 15, 2011

Enhanced Albumin Fusion Technology

November 15, 2011

Directing Cell-Signaling Research

November 1, 2011

Cutting-Edge Approaches and Applications for RNAi

November 1, 2011

Retooling SBIR Not That Easy

November 1, 2011

Personalized Medicine Diagnostic Patents

November 1, 2011

Solution Supplier Expands Offerings

November 1, 2011

Vaccine Market Revenue Growing

November 1, 2011

GEN’s 30th Anniversary: Peptide Therapeutics

November 1, 2011

Volatility Rattles Biotechnology Sector

November 1, 2011

Gene Cloning and Colony Picking

November 1, 2011

Detection of Lysine Deacetylase Activities

November 1, 2011

Green Chemistry Initiatives Take Shape

November 1, 2011

Getting the Most from Process Operations

November 1, 2011

Producing Recombinant Virus-Like Particles

November 1, 2011

Redefining High-Resolution Mass Spec

November 1, 2011

Regen Med Success Hinges on Engineering

November 1, 2011

Gene Therapy Briefs

November 1, 2011

Dementia Studies Making Strides

October 17, 2011

Target-Enrichment Field Continuing to Expand

October 17, 2011

Driving Down Medical and Healthcare Spending

October 17, 2011

Profiling Platform Delves Into Tumors

October 17, 2011

Prenatal Markets Remain Strong and Fertile

October 17, 2011

GEN’s 30th Anniversary: HIV/AIDS

October 17, 2011

Can the FDA Be a Catalyst for Innovation?

October 17, 2011

Two Technologies Are Better Than One

October 17, 2011

Amplifying Immunoassay Sensitivity

October 17, 2011

Identifying Promising Drug Candidates

October 17, 2011

RNA Assumes More Prominent Role

October 17, 2011

Cell Culture Central to Upstream Scaleup

October 17, 2011

Single-Use Systems Growth Rate Plateauing

October 17, 2011

Protein Bioproduction without Antibiotics

October 17, 2011

Implementing CIMS for Process Operations

October 17, 2011

Tracking Key Biomanufacturing Trends

October 17, 2011

PCR-Based Diagnostics Put to the Test

October 17, 2011

USP Improves Biologic Quality Standards

October 17, 2011

Microplate Replacement for HT Screening

October 15, 2011

Overcoming Downstream Bottlenecks

October 15, 2011

From the Publisher: 30 Years and Counting!

October 3, 2011

Tracking Operational Financing Trends

October 3, 2011

Biological Complexity Under Attack

October 3, 2011

Proteomics: Pathways and Biomarkers

October 3, 2011

Success in Biotech Depends on Timing

October 3, 2011

Highlighting the Course of Biotech Law

October 3, 2011

Viewing Biotech as a Social Drama

October 3, 2011

RNAi Efforts Ready to Pay Dividends

October 3, 2011

Evolution of Polymerase Chain Reaction

October 3, 2011

Future of DNA Sequencing Technology

October 3, 2011

Epigenetics and Reinventing Lamarck

October 3, 2011

Protein Expression Technology Review

October 3, 2011

Creating Modern Industrial Microbiology

October 3, 2011

Purification Methods in Biomanufacturing

October 3, 2011

Single-Use Cell Culture Systems Arrive

October 3, 2011

Combating Infectious Disease Agents

October 3, 2011

Natural Progression of Synthetic Biology

October 3, 2011

The History and Promise of Gene Therapy

October 3, 2011

Advertorial: AMRESCO

October 3, 2011

Advertorial: ATR

October 3, 2011

Advertorial: Beckman Coulter

October 3, 2011

Advertorial: Beckman Coulter Genomics

October 3, 2011

Advertorial: BIOBASE

October 3, 2011

Advertorial: CEVEC Pharmaceuticals

October 3, 2011

Advertorial: Charles River

October 3, 2011

Advertorial: Cisbio Assays

October 3, 2011

Advertorial: Cook Pharmica

October 3, 2011

Advertorial: DASGIP

October 3, 2011

Advertorial: Douglas Scientific

October 3, 2011

Advertorial: DSM Biologics

October 3, 2011

Advertorial: Flexicon

October 3, 2011